GlassScriptPhysician profile
Jenifer Reddy
NPI 1336134006
$3,461.68
in general payments reported to CMS, 2019-2025
34 companies · $26.72 in 2025
The $26.72 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $223 · 2021: $327 · 2022: $823 · 2023: $533 · 2024: $1,028 · 2025: $26.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,508.44 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $495.19 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $441.33 | 2022-2024 | Sotyktu |
| Pfizer INC. | $298.99 | 2019-2024 | |
| Janssen Biotech, INC. | $272.66 | 2021-2024 | Tremfya |
| Incyte Corporation | $243.95 | 2021-2024 | Opzelura |
| Biofrontera INC. | $236.96 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Leo Pharma INC. | $155.19 | 2023-2025 | Adbry |
| Lilly USA, LLC | $146.79 | 2019-2024 | Olumiant |
| Amgen INC. | $129.14 | 2022-2024 | Otezla |
| Depuy Synthes Sales INC. | $124.87 | 2022 | |
| Urgo Medical North America, LLC | $82.16 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Verrica Pharmaceuticals INC. | $72.55 | 2023-2024 | Ycanth |
| Sun Pharmaceutical Industries INC. | $65.16 | 2022-2023 | Winlevi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $58.10 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $56.31 | 2021-2022 | |
| Dermira, INC. | $55.71 | 2019 | |
| Convatec INC. | $52.27 | 2024 | |
| Mimedx Group, INC. | $49.83 | 2024 | |
| W. L. Gore & Associates, INC. | $46.15 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.81 | 2023-2024 | Spevigo |
| Smith+Nephew, INC. | $40.59 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $30.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.33 | 2022 | |
| Mission Pharmacal Company | $25.18 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $23.93 | 2019 | |
| Polynovo North America LLC | $21.77 | 2022 | |
| Ucb, INC. | $20.23 | 2024 | Bimzelx |
| Genzyme Corporation | $19.86 | 2022 | |
| Reapplix INC. | $17.63 | 2021 | |
| Almirall LLC | $12.90 | 2019 | |
| Galderma Laboratories, L.P. | $11.67 | 2019 | |
| Kci USA, INC. | $11.16 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $9.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenifer Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.